MEPs are divided over EU rules on new types of treatment for diseases such as cancer or Alzheimer's, with conservative deputies calling for safeguards against medicines developed through embryonic stem cell research, a practice that is illegal in some countries.
After a series of delays, the European Parliament is set to vote on Wednesday (25 April) on the new EU regulation on so called "advanced therapies" - gene therapy, adult stem cell therapy and tissue engineering.
All three...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? Login